AGÕæÈ˹ٷ½

STOCK TITAN

International Flavors&Fragranc SEC Filings

IFF NYSE

Welcome to our dedicated page for International Flavors&Fragranc SEC filings (Ticker: IFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking IFF’s performance means navigating disclosures on everything from bioscience breakthroughs to fragrance royalty streams—hundreds of pages that can slow even seasoned analysts. IFF’s 10-K details multi-billion-dollar goodwill, while each 10-Q updates raw-material inflation and segment margins. Form 4 insider activity often hints at confidence in new enzyme launches. Finding these signals quickly is the challenge.

Stock Titan solves that challenge with AI-powered summaries and real-time alerts. Our platform ingests every filing the moment it hits EDGAR, then explains complex sections in plain English. Need the latest IFF quarterly earnings report 10-Q filing? You’ll see key Nourish revenue shifts and inventory movements without wading through footnotes. Curious about IFF insider trading Form 4 transactions? Instant dashboards flag executive stock moves and link back to the source document.

All filing types are covered:

  • Annual report 10-K simplified—segment outlook, intangible asset tests, sustainability metrics
  • 8-K material events explained—plant expansions, acquisition updates, leadership changes
  • Proxy statement executive compensation—R&D incentives and equity awards
  • Form 4 insider transactions real-time—buying and selling patterns before product launches
Understanding IFF SEC documents with AI means faster decisions: compare quarter-over-quarter fragrance growth, monitor supply-chain risk disclosures, and run earnings report filing analysis in seconds. No more scrolling—just the insights that matter to investors, credit analysts, and procurement teams following this global ingredients leader.

Rhea-AI Summary

Alignment Healthcare (ALHC) Q2-25 10-Q highlights

Revenue climbed 49% year-over-year to $1.015 bn, driven by earned premiums of $1.006 bn. Medical expenses grew 46% to $881.7 m, but the medical loss ratio improvement helped swing operating results to a $22.7 m profit versus a $18.4 m loss in Q2-24. Net income attributable to shareholders reached $15.7 m, or $0.07 diluted EPS, reversing the prior-year $(0.13) loss.

For the first six months, revenue rose 48% to $1.94 bn with net income of $6.6 m. Cash and equivalents increased to $470.3 m, supporting total assets of $1.0 bn. Long-term debt stayed at $322.3 m after the Nov-24 issuance of 4.25% convertible notes; quarterly interest expense fell to $4.0 m. Stockholdersâ€� equity improved to $141.0 m as the accumulated deficit narrowed.

Key ratios

  • Operating margin: 2.2% vs (2.7)% YoY
  • Medical expenses/Revenue: 86.9% vs 88.8%
  • Cash & short-term investments: $505.8 m

Management noted an immaterial exit from the ACO REACH model effective 31-Dec-25 and confirmed compliance with all RBC/TNE capital rules. No new financial guidance was issued.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
current report
-
Rhea-AI Summary

Insider Transaction Overview (Form 4)

Nextracker Inc. (ticker: NXT) disclosed that Chief Operating Officer Nicholas Marco Miller sold 946 shares of common stock on July 1, 2025 at $54.27 per share. The transaction was conducted under a Rule 10b5-1 trading plan adopted on March 13, 2025.

Following the sale, Miller’s directly held position stands at 169,054 shares. No derivative securities were exercised, acquired or disposed of during the reporting period, and no additional transactions were reported.

The disposal represents roughly 0.56 % of the executive’s disclosed direct holdings, indicating a modest portfolio adjustment rather than a significant off-load. Because the trade was pre-arranged and involves a small fraction of total ownership, the filing is generally viewed as neutral from a market-signal perspective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

International Flavors & Fragrances (NYSE: IFF) reports a Form 3 filing indicating the initial beneficial ownership of Virginia Drosos, who has joined as a Director of the company effective June 16, 2025.

Key details of the beneficial ownership:

  • Virginia Drosos owns 99 shares of IFF common stock directly
  • Position: New Director appointment
  • No derivative securities (options, warrants, etc.) reported
  • Filing submitted via attorney-in-fact Chrystalla Potamitou on June 19, 2025

The Form 3 filing, required by Section 16(a) of the Securities Exchange Act, establishes Ms. Drosos's initial position as a company insider. Her business address is listed as 521 West 57th Street, New York, NY.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of International Flavors&Fragranc (IFF)?

The current stock price of International Flavors&Fragranc (IFF) is $69.48 as of August 1, 2025.

What is the market cap of International Flavors&Fragranc (IFF)?

The market cap of International Flavors&Fragranc (IFF) is approximately 18.4B.

What does IFF specialize in?

IFF specializes in providing specialty ingredients and proprietary formulations in flavors, fragrances, food ingredients, health, and biosciences.

How does IFF generate revenue?

IFF generates revenue primarily through the production and sale of customized ingredient solutions and proprietary formulations, developed through strategic partnerships and advanced R&D.

Which industries does IFF serve?

IFF serves a range of industries including food and beverage, health and personal care, pharmaceuticals, household goods, and industrial applications.

What differentiates IFF from its competitors?

IFF differentiates itself through its unique integration of scientific research and creative innovation, delivering bespoke, high-performance ingredients and sensory experiences tailored to specific market needs.

How does IFF approach innovation?

IFF employs a customer-centric approach combined with cutting-edge research, leveraging advanced technologies such as AI, enzyme research, and immersive consumer insights to drive continuous innovation.

In what ways does IFF collaborate with customers?

IFF partners closely with customers to co-create solutions, offering custom formulation services and technical support to address specific challenges and enhance product performance.

What is the significance of IFF's global presence?

IFF's global presence ensures it can combine local consumer insights with a worldwide perspective, enabling tailored solutions that meet diverse regulatory and market requirements.

How does IFF ensure product quality?

Through strict quality assurance protocols and state-of-the-art manufacturing processes, IFF guarantees that every formulation and ingredient meets rigorous performance and regulatory standards.
International Flavors&Fragranc

NYSE:IFF

IFF Rankings

IFF Stock Data

18.36B
255.51M
0.08%
96.45%
1.8%
Specialty Chemicals
Industrial Organic Chemicals
United States
NEW YORK